Background Magnetic resonance cholangiography (MRC) is a non-invasive metho
d of imaging the biliary tree with virtually no morbidity, Endoscopic retro
grade cholangiopancreatography (ERCP) has a significant morbidity, mortalit
y and failed imaging rate. Unlike MRC, ERCP is highly dependent on the clin
ical team for high-quality results and minimal morbidity. MRC requires high
-quality image acquisition and appropriate reconstructions, with skilled re
ading of the images.
Objectives To assess the impact on ERCP workload of using MRC as the initia
l imaging modality for the biliary tree in selected patient groups, and to
assess procedure-related morbidity and mortality.
Methods An analysis of 1078 consecutive ERCP examinations performed at our
institution over the six years to 1996 has been undertaken. Complications,
imaging failure rates and ERCP findings have been analysed in the different
referral categories to assess the potential impact of MRC on future ERCP w
orkload and patient outcomes.
Results At our institution, if MRC had been used as the first imaging inves
tigation in patients with abdominal pain (n = 336, with or without abnormal
liver function tests but without clinical jaundice) and those with present
or past acute pancreatitis (n = 101), we estimate that 83 (19%) would have
needed to go on to ERCP, but 354 (81%) would not have required further inv
asive investigation. In these categories, this would have resulted in five
patients with stones missed at MRC, but 14 extra patients with stones would
have been identified whose stones would have been missed at ERCP (failed e
xaminations). There would be an overall 33% reduction in ERCP workload and
20 serious complications related to ERCP would have been avoided. Overall 7
% of patients would be subjected to both investigations.
Conclusions In the interests of efficient use of resources, minimization of
patient complications and accurate identification of those requiring thera
peutic ERCP, MRC should be the preferred initial investigation in selected
groups of patients presently being subjected to ERCP. Eur J Gastroenterol H
epatol 12:773-776 (C) 2000 Lippincott Williams & Wilkins.